Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient Characteristics and Concerns about Drug Allergy: A Report from the United States Drug Allergy Registry.
Blumenthal KG, Harkness T, Phillips EJ, Ramsey A, Banerji A, Samarakoon U, Stone C, Fu X, Khan DA, Otani I, Camargo CA Jr, Zhang Y, Donelan K; USDAR Study Team. Blumenthal KG, et al. Among authors: harkness t. J Allergy Clin Immunol Pract. 2020 Oct;8(9):2958-2967. doi: 10.1016/j.jaip.2020.08.018. Epub 2020 Aug 24. J Allergy Clin Immunol Pract. 2020. PMID: 32853819
Small molecule nitroalkenes inhibit RAD51-mediated homologous recombination and amplify triple-negative breast cancer cell killing by DNA-directed therapies.
Hong L, Braden DC, Zhao Y, Skoko JJ, Chang F, Woodcock SR, Uvalle C, Casey A, Wood K, Salvatore SR, Asan A, Harkness T, Fagunloye A, Razzaghi M, Straub A, Spies M, Brown DD, Lee AV, Schopfer F, Freeman BA, Neumann CA. Hong L, et al. Among authors: harkness t. bioRxiv [Preprint]. 2023 Aug 14:2023.08.11.552990. doi: 10.1101/2023.08.11.552990. bioRxiv. 2023. Update in: Redox Biol. 2023 Oct;66:102856. doi: 10.1016/j.redox.2023.102856 PMID: 37645906 Free PMC article. Updated. Preprint.
Small molecule nitroalkenes inhibit RAD51-mediated homologous recombination and amplify triple-negative breast cancer cell killing by DNA-directed therapies.
Hong L, Braden DC, Zhao Y, Skoko JJ, Chang F, Woodcock SR, Uvalle C, Casey A, Wood K, Salvatore SR, Asan A, Harkness T, Fagunloye A, Razzaghi M, Straub A, Spies M, Brown DD, Lee AV, Schopfer F, Freeman BA, Neumann CA. Hong L, et al. Among authors: harkness t. Redox Biol. 2023 Oct;66:102856. doi: 10.1016/j.redox.2023.102856. Epub 2023 Aug 19. Redox Biol. 2023. PMID: 37633047 Free PMC article.
Assessment of patient-reported symptoms and distress in IgG4-related disease (IgG4-RD): Development, clinical validation, and content validation of the IgG4-RD Symptom Severity Index.
Wallace ZS, McMahon GA, Hang B, Fu X, Harkness T, Donelan K, Fernandes A, Cook C, Katz G, Perugino C, Stone JH. Wallace ZS, et al. Among authors: harkness t. Semin Arthritis Rheum. 2023 Dec;63:152253. doi: 10.1016/j.semarthrit.2023.152253. Epub 2023 Aug 18. Semin Arthritis Rheum. 2023. PMID: 37619485 Free PMC article.
Activation of the Anaphase Promoting Complex Reverses Multiple Drug Resistant Cancer in a Canine Model of Multiple Drug Resistant Lymphoma.
Arnason TG, MacDonald-Dickinson V, Gaunt MC, Davies GF, Lobanova L, Trost B, Gillespie ZE, Waldner M, Baldwin P, Borrowman D, Marwood H, Vizeacoumar FS, Vizeacoumar FJ, Eskiw CH, Kusalik A, Harkness TAA. Arnason TG, et al. Among authors: harkness taa. Cancers (Basel). 2022 Aug 30;14(17):4215. doi: 10.3390/cancers14174215. Cancers (Basel). 2022. PMID: 36077749 Free PMC article.
79 results